Stratos Wealth Partners, LTD.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1612865
BEACHWOOD, OH
Position in VRTX
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$1,473,135
-$22,499 QoQ
Shares Held
3,299
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Stratos Wealth Partners, LTD. holds $11,734,127 across 20 Biotechnology names. VRTX ranks #2 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZVRA |
Zevra Therapeutics, Inc.
|
408,000 | $3,802,560 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
3,299 | $1,473,135 | |
| 3 | PHAT |
Phathom Pharmaceuticals, Inc.
|
100,000 | $1,111,000 | |
| 4 | PLX |
Protalix BioTherapeutics, Inc.
|
500,000 | $1,085,000 | |
| 5 | INCY |
Incyte Corp
|
6,895 | $648,957 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,715 | $579,319 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
6,640 | $493,086 | |
| 8 | EXEL |
Exelixis, Inc.
|
9,093 | $389,998 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,473,135 | 3,299 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,495,634 | 3,299 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,210,950 | 3,092 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,425,085 | 3,201 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $2,076,968 | 4,284 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,166,928 | 5,381 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $2,630,027 | 5,655 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $2,679,672 | 5,717 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $2,208,346 | 5,283 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $1,271,938 | 3,126 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $1,048,436 | 3,015 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,182,065 | 3,359 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $983,648 | 3,122 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $1,143,568 | 3,960 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $949,401 | 3,279 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $866,222 | 3,074 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $751,071 | 2,878 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $581,940 | 2,650 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $532,016 | 2,933 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $481,895 | 2,390 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $519,604 | 2,418 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $347,892 | 1,472 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $379,335 | 1,394 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $590,780 | 2,035 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $225,814 | 949 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||